← FDA Drug Approvals (Drugs@FDA)
RYTELO
NDA · New Drug Application · Sponsor: GERON · Approved 2024-06-06
Drug application
- FDA Application #
NDA217779- Application type
- New Drug Application
- Brand name
- RYTELO
- Generic name
- IMETELSTAT SODIUM
- Active ingredients
- IMETELSTAT SODIUM
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- GERON
- Manufacturer
- Geron Corporation
- First approval
- 2024-06-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown